Hydroxyurea ≥98% Ribonucleotide reductase inhibitor
À propos de cet article
Ribonucleotide reductase inhibitor. Various biological activities including anticancer and antiretroviral properties. Induces apoptosis in vitro.
: All products are FOR RESEARCH USE ONLY. PRODUCTS ARE NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES. Customer is granted a limited use non-exclusive licence for its own internal research. Any control manufacturer supplies with a Product is limited to use only to validate the relevant Product. By using the Product, Customers agree not to attempt to reverse engineer or otherwise perform any compositional, structural, functional or other analyses directed to learning the methodology, formulae, sequences, processes, make-up or production of any of the Products or portions thereof.
- Numéro CAS:127-07-1
- Poids moléculaire:76,055 g/mol
2 Options disponibles ci-dessous
Product Details & Documents
Ribonucleotide reductase inhibitor. Various biological activities including anticancer and antiretroviral properties. Induces apoptosis in vitro.
: All products are FOR RESEARCH USE ONLY. PRODUCTS ARE NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES. Customer is granted a limited use non-exclusive licence for its own internal research. Any control manufacturer supplies with a Product is limited to use only to validate the relevant Product. By using the Product, Customers agree not to attempt to reverse engineer or otherwise perform any compositional, structural, functional or other analyses directed to learning the methodology, formulae, sequences, processes, make-up or production of any of the Products or portions thereof.
- Numéro CAS:127-07-1
- Poids moléculaire:76,055 g/mol
Spécifications de la famille de produits
Résultats des tests de spécification
- Constituents::98% Hydroxyurea
Product Family Options
Les recommandations seront personnalisées en fonction de vos préférences d’achat uniquement si vous avez donné votre consentement en activant l’option " Améliorer mon expérience d’achat " sur la page "Mon compte".
Dans le cas contraire, vous recevrez des recommandations génériques.



